Chison Medical Technologies Co., Ltd. (SHA:688358)
38.58
+0.56 (1.47%)
At close: Jan 23, 2026
SHA:688358 Revenue
Chison Medical Technologies had revenue of 107.01M CNY in the quarter ending September 30, 2025, a decrease of -6.68%. This brings the company's revenue in the last twelve months to 449.62M, up 1.20% year-over-year. In the year 2024, Chison Medical Technologies had annual revenue of 468.70M, down -3.13%.
Revenue (ttm)
449.62M
Revenue Growth
+1.20%
P/S Ratio
9.60
Revenue / Employee
837.28K
Employees
537
Market Cap
4.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 468.70M | -15.14M | -3.13% |
| Dec 31, 2023 | 483.84M | 103.00M | 27.04% |
| Dec 31, 2022 | 380.84M | -16.97M | -4.27% |
| Dec 31, 2021 | 397.81M | 64.72M | 19.43% |
| Dec 31, 2020 | 333.09M | -36.66M | -9.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.05B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Ningbo David Medical Device | 516.76M |
| Dirui Industrial | 511.11M |
| Nanjing Medlander Medical Technology | 437.82M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |